# Enterobiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enterobiome

- Industry: Biotechnology
- Headquarters: Goyang, South Korea
- Website: www.enterobiome.com
- Total disclosed funding: $14M
- Latest round: Series B (Nov 30, 2021)
- Investors on record: 7

## About

Based in Goyang-si, South Korea, and founded in 2018, Enterobiome Inc. is a microbiome-based new drug development company. Jaegu Seo serves as the CEO of the company as of 2021. In November 2021, ENTEROBIOM raised KRW 11 billion in series B funding from returning investors Hanwha Investment & Securities, HB Investment, Intops Investment, Lighthouse Combined Investment, and Magna Investments.

The company develops treatments for intractable diseases such as cancer, obesity, diabetes, non-alcoholic liver disease, and atopy based on the species living in the intestinal mucosa of humans. The company has developed its own culture technology and is applying it to prototype production and has created a library of anaerobic strains to be developed as therapeutic agents.

The series B investment received in November 2021 will help Enterobiome Inc. in the production of its prototypes and in the development of new microbiome drugs.

## Funding rounds

- Series B, Nov 30, 2021, $9.2M — HB Investment, Magna Investment, Lighthouse Combined Investment, Intops Investment, Hanwha Investment & Securities
- Series A, Jan 12, 2021, $4.8M — HB Investment, IBK Capital, Magna Investment, Lighthouse Combined Investment, Intops Investment, Hanwha Investment & Securities
- Seed, May 1, 2019 — Magna Investment, Korea Tech Incubator for Startup

## Investors

- Magna Investment (https://capitalatlas.ai/funds/magna-investment) — Seed, Series A, Series B
- Korea Tech Incubator for Startup — Seed
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series A, Series B
- IBK Capital (https://capitalatlas.ai/funds/ibk-capital) — Series A
- Lighthouse Combined Investment (https://capitalatlas.ai/funds/lighthouse-combined-investment) — Series A, Series B
- Intops Investment (https://capitalatlas.ai/funds/intops-investment) — Series A, Series B
- Hanwha Investment & Securities (https://capitalatlas.ai/funds/hanwha-investment-securities) — Series A, Series B